Evidence map›Paper›PMID 32864575›Full record

ReviewSN comprehensive clinical medicine2020

Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses.

Sabhiya Majid, Rabia Farooq, Mosin S Khan, Samia Rashid, Showkat A Bhat, Hilal A Wani, Waseem Qureshi

Registry-linked trialAbstract readReview
In one paragraph

Review in SN comprehensive clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06597370 (Immunogenicity Induced by COVID-19 Vaccines in Mexican Population), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06597370 completednot on this mapstarted 2021, after this paper: background citation

Immunogenicity Induced by COVID-19 Vaccines in Mexican Population: mRNA Expression for IgG Anti-spike

Typeobservational_patient_registrySponsorNational Polytechnic Institute, MexicoRan2021 to 2021Enrolled80ConditionsCOVID-19 VaccineArmsGene expression mRNA of IgG anti-spike
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sabhiya MajidDepartment of Biochemistry, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.ORCID 0000-0002-3678-3313
Rabia FarooqDepartment of Biochemistry, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.
Mosin S KhanDepartment of Biochemistry, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.
Samia RashidDepartment of Medicine, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.
Showkat A BhatDepartment of Biochemistry, Government Medical College Doda, Doda, J&K 182202 India.
Hilal A WaniDepartment of Biochemistry, Government Medical College Srinagar and Associated Hospitals , Srinagar, J&K 190010 India.
Waseem QureshiRegistrar Academics, Government Medical College Srinagar, Srinagar, J&K 190010 India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19), an ongoing global health emergency, is a highly transmittable and pathogenic viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Emerging in Wuhan, China, in December 2019, it spread widely across the world causing panic-worst ever economic depression is visibly predictable. Coronaviruses (CoVs) have emerged as a major public health concern having caused three zoonotic outbreaks; severe acute respiratory syndrome-CoV (SARS-CoV) in 2002-2003, Middle East respiratory syndrome-CoV (MERS-CoV) in 2012, and currently this devastating COVID-19. Research strategies focused on understanding the evolutionary origin, transmission, and molecular basis of SARS-CoV-2 and its pathogenesis need to be urgently formulated to manage the current and possible future coronaviral outbreaks. Current response to the COVID-19 outbreak has been largely limited to monitoring/containment. Although frantic global efforts for developing safe and effective prophylactic and therapeutic agents are on, no licensed antiviral treatment or vaccine exists till date. In this review, research strategies for coping with COVID-19 based on evolutionary and molecular aspects of coronaviruses have been proposed.

Indexed as

CoronavirusCOVID-19MERS-CoVSARS-CoVSARS-CoV-2

Identifiers

PMID32864575
PMCPMC7445016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.